Health Care • Biotechnology: Pharmaceutical Preparations
$97.56 ▲ +2.38
(+2.50%)
MKT CAP: $7.67B • VOL: 1.38M
52W L $37 52W H $98
KNSA CHAT <GO> // SEC 10-K & XBRL FORENSIC RAGKiniksa Pharmaceuticals International plc Class A • CIK 0001730430
EDGAR XBRL + ITEM 1A/7FREE QUERIES: 2/2
INSTITUTIONAL AUDIT PROMPTS [CLICK TO EXECUTE]STRUCTURED CITATION ENGINE
[READY // SEC EDGAR & XBRL VECTOR WORKSTATION]
Select an audit prompt above or enter any fundamental, 10-K Risk Factor (Item 1A), MD&A (Item 7), free cash flow conversion, or FRED macro-correlation query on KNSA. Every response cites verified XBRL line items and SEC filing sections.